MORRISVILLE, NC / ACCESS Newswire / February 12, 2026 / Clinical trials are the research studies required to test the ...
RESEARCH TRIANGLE PARK, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the ...
RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...
MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced the appointment of Kelly Johnston McKee as Vice President, ...
RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading Metasite TM, today announced the launch of a stand-alone Patient ...
Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...
New release sets the bar as the most comprehensive platform to orchestrate decentralized study conduct—unifying stakeholder journeys, increasing compliance, and generating the highest-quality data for ...
“After an extensive review of opportunities available to Science 37, we believe that eMed provides the greatest value to our stockholders, customers, patients, and employees” said David Coman, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results